Greenwich LifeSciences (GLSI) Financials: Revenue & Earnings

GLSI price $17.23 -0.20 -1.12%

Ticker
GLSI
Price
$17.23
Change
-0.20 -1.12%
Market cap ?
$252.83M
P/E ?
-11.12
Forward P/E ?
4.33
Dividend yield ?
0.00%
Beta ?
1.46
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
56
Quality
43
Growth
100

Stocklytics score rationale: value 56, quality 43, growth 100.

Financials

201720182019202020212022202320242025
000000000

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of…

Fair value

GLSI fair value $155.59. Price $17.23. Price is 89% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare GLSI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—-0.30——
2026-08-11-0.27-0.33——
2026-06-03-0.39-0.33——
2026-03-31-0.32-0.32——
2025-11-14-0.30-0.30——
2025-08-14-0.30-0.24——
2025-05-20-0.25-0.24——
2025-04-15-0.61-0.213.61K—
2024-11-14-0.20-0.21——
2024-08-14-0.20-0.20——
2024-05-20-0.19-0.20——
2024-04-15-0.21-0.205.42K—
2023-10-19-0.19-0.22——
2023-08-21-0.13-0.23——
2023-05-22-0.17-0.23——
2023-03-31-0.22-0.18——
2022-11-14-0.18-0.19——
2022-08-15-0.06-0.19——
2022-05-20-0.15-0.19——
2022-03-21-0.18-0.07——
2021-11-15-0.07-0.06——
2021-08-13-0.06———
2021-05-20-0.05-0.26——
2021-03-31-0.12-0.93——
2020-11-16-0.02———
2020-09-28-0.02———
2020-03-31-0.02———
2019-12-31-0.03———
2019-09-30-0.03———
2019-06-30-0.22———
2019-03-31-0.01———
2018-12-31-0.13———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-29Patel SnehalBuy700$13.109.17K
2026-07-28Patel SnehalBuy1.50K$13.5920.39K
2026-07-27Patel SnehalBuy1.50K$13.6220.43K
2026-07-24Patel SnehalBuy1.10K$12.8814.17K
2026-07-23Patel SnehalBuy2.50K$13.1432.85K
2026-01-13Patel SnehalBuy1.80K$29.8353.69K
2026-01-12Patel SnehalBuy2.90K$27.5479.87K
2025-12-31Patel SnehalBuy4.30K$21.3691.85K
2025-12-30Patel SnehalBuy2.90K$21.7363.02K
2025-12-18Patel SnehalBuy4.10K$12.6251.74K
2025-11-25Patel SnehalBuy4.60K$8.3738.50K
2025-11-13Patel SnehalBuy100.00K$8.20820.00K
2025-11-07Patel SnehalBuy10.60K$8.4389.36K
2025-10-31Patel SnehalBuy2.30K$9.2621.30K
2025-04-25Patel SnehalBuy3.60K$9.8835.57K
2025-04-17Patel SnehalBuy5.40K$8.9848.49K
2025-04-07Patel SnehalBuy3.60K$9.1032.76K
2025-04-04Patel SnehalBuy5.50K$8.7348.02K
2025-01-10Patel SnehalBuy2.50K$12.5131.27K
2025-01-07Patel SnehalBuy1.80K$13.7524.75K
2025-01-06Patel SnehalBuy1.10K$13.3114.64K
2025-01-03Patel SnehalBuy3.40K$12.9544.03K
2025-01-02Patel SnehalBuy2.00K$11.9723.94K
2024-12-31Patel SnehalBuy2.40K$11.3627.26K
2024-12-30Patel SnehalBuy3.20K$11.1235.58K
2024-12-24Daugherty Frank JosephBuy104.89K$12.161.28M
2024-12-24Hallock KennethBuy41.35K$12.16502.80K
2024-12-24Patel SnehalBuy25.01K$12.16304.10K
2024-12-24Patel SnehalBuy1.15M$12.1613.97M
2024-12-24Rothe EricBuy41.35K$12.16502.80K
2024-12-24Thompson JayeBuy149.82K$12.161.82M
2024-12-24McWilliams DavidBuy61.98K$12.16753.73K
2024-11-21Thompson JayeBuy1.00K$12.9112.91K
2024-09-26Patel SnehalBuy1.50K$14.6321.95K
2024-08-12Thompson JayeBuy800$13.8511.08K
2024-08-06Patel SnehalBuy2.00K$13.8127.62K
2024-08-05Patel SnehalBuy5.50K$13.1872.49K
2024-08-02Thompson JayeBuy1.00K$15.1515.15K
2024-07-23Patel SnehalBuy1.50K$15.8923.84K
2024-07-18Thompson JayeBuy1.00K$16.0016.00K
2024-06-13Patel SnehalBuy174.82K$14.302.50M
2024-04-01Patel SnehalBuy3.00K$19.0857.24K
2024-03-22Patel SnehalBuy2.50K$19.9849.95K
2024-03-20Patel SnehalBuy1.50K$17.6826.52K
2024-03-05Patel SnehalBuy30.50K$12.49380.94K
2024-03-04Patel SnehalBuy4.10K$13.0353.42K
2024-02-16Patel SnehalBuy10.80K$11.16120.53K
2024-02-15Patel SnehalBuy12.70K$11.07140.59K
2023-11-10Patel SnehalBuy5.00K$10.1750.84K
2023-11-03Patel SnehalBuy3.50K$9.1131.88K
2023-10-27Thompson JayeBuy500$8.574.29K
2023-10-26Patel SnehalBuy2.50K$7.9719.93K
2023-10-25Patel SnehalBuy2.50K$7.9119.77K
2023-10-10Patel SnehalBuy1.00K$9.079.07K
2023-10-04Patel SnehalBuy2.00K$8.6317.26K
2023-09-26Thompson JayeBuy600$8.715.23K
2023-09-19Patel SnehalBuy4.00K$8.9535.80K
2023-09-11Patel SnehalBuy1.00K$9.489.48K
2023-08-22Patel SnehalBuy1.00K$9.979.97K
2023-08-04Patel SnehalBuy2.00K$10.5521.10K
2023-07-21Patel SnehalBuy1.00K$9.209.20K
2023-07-13Thompson JayeBuy250$9.492.37K
2023-05-17Patel SnehalBuy1.00K$11.6911.69K
2023-04-28Thompson JayeBuy250$11.222.81K
2023-04-19Patel SnehalBuy7.00K$11.1077.70K
2023-04-18Patel SnehalBuy2.00K$11.1222.24K
2023-04-11Thompson JayeBuy1.00K$11.8711.87K
2023-04-11Patel SnehalBuy5.00K$12.4262.10K
2023-03-15Thompson JayeBuy250$12.713.18K
2023-03-10Patel SnehalBuy1.00K$12.1212.12K
2023-02-24Thompson JayeBuy250$15.393.85K
2023-02-17Patel SnehalBuy600$16.539.92K
2023-02-10Patel SnehalBuy1.00K$18.6818.68K
2023-02-03Thompson JayeBuy250$20.845.21K
2023-01-27Patel SnehalBuy2.00K$19.3538.70K
2023-01-27Thompson JayeBuy250$19.204.80K
2023-01-20Patel SnehalBuy1.50K$17.3726.05K
2023-01-13Thompson JayeBuy250$16.504.12K
2023-01-06Patel SnehalBuy1.50K$15.1822.77K
2022-12-29Patel SnehalBuy4.00K$15.1960.76K
2022-12-16Patel SnehalBuy1.00K$13.0113.01K
2022-12-16Thompson JayeBuy250$12.943.23K
2022-12-09Patel SnehalBuy2.00K$13.1126.22K
2022-12-02Patel SnehalBuy1.00K$13.8413.84K
2022-12-02Thompson JayeBuy250$13.983.50K
2022-11-02Patel SnehalBuy2.00K$8.7917.58K
2022-10-14Patel SnehalBuy3.00K$9.7529.25K
2022-10-07Patel SnehalBuy2.00K$9.7219.44K
2022-09-30Patel SnehalBuy1.00K$9.469.46K
2022-09-29Patel SnehalBuy1.00K$9.239.23K
2022-06-24Patel SnehalBuy22.54K$9.13205.74K
2022-06-22Daugherty Frank JosephBuy104.89K$7.63800.31K
2022-06-22Daugherty Frank JosephBuy104.89K——
2022-06-22Patel SnehalBuy25.01K——
2022-06-22Thompson JayeBuy149.82K——
2022-06-22Hallock KennethBuy41.35K$7.63315.49K
2022-06-22Hallock KennethBuy41.35K——
2022-06-22Rothe EricBuy41.35K——
2022-06-22McWilliams DavidBuy61.98K——
2022-06-16Patel SnehalBuy8.00K$7.1357.04K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 60, holders -3 vs prior quarter. Ownership 11.66%.

HolderSharesChangeChange %Value
BLACKROCK, INC.485.85K51.99K+11.98%11.40M
VANGUARD CAPITAL MANAGEMENT LLC278.19K-20.08K-6.73%6.53M
GEODE CAPITAL MANAGEMENT, LLC168.18K12.71K+8.18%3.95M
STATE STREET CORP143.09K9.21K+6.88%3.36M
VANGUARD PORTFOLIO MANAGEMENT LLC80.86K21.95K+37.26%1.90M
NORTHERN TRUST CORP80.23K5.10K+6.79%1.88M
BANK OF NEW YORK MELLON CORP47.90K1.38K+2.96%1.12M
VANGUARD FIDUCIARY TRUST CO45.97K1.06K+2.35%1.08M
MORGAN STANLEY43.45K13.62K+45.66%1.02M
GOLDMAN SACHS GROUP INC39.33K-192-0.49%922.66K
RUSSELL INVESTMENTS GROUP, LTD.34.35K-5.34K-13.46%805.94K
JANE STREET GROUP, LLC27.69K27.69KNew649.70K
UBS GROUP AG23.41K2.29K+10.86%549.17K
STATE OF WISCONSIN INVESTMENT BOARD22.64K2.30K+11.31%531.11K
GSA CAPITAL PARTNERS LLP19.54K19.54KNew458.00K
MASSACHUSETTS FINANCIAL SERVICES CO /MA/17.92K17.92KNew420.45K
STRS OHIO17.80K4.10K+29.93%417.59K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.17.10K17.10KNew401.12K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC17.10K495+2.98%401.12K
VANGUARD GLOBAL ADVISERS, LLC11.87K1.54K+14.86%278.49K
ANCORA ADVISORS LLC10.74K-26.76K-71.36%251.96K
STIFEL FINANCIAL CORP10.02K10.02KNew235.14K
RAYMOND JAMES FINANCIAL INC9.14K-700-7.12%214.35K
RHUMBLINE ADVISERS8.39K341+4.24%196.75K
WELLS FARGO & COMPANY/MN6.14K3.70K+151.80%144.14K

Earnings and financials

Greenwich LifeSciences, Inc. (GLSI) trades at $17.23, with a market cap of $252.83M and a trailing P/E of -11.12. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Greenwich LifeSciences (GLSI) Financials: Revenue & Earnings

GLSI$17.23-0.20 -1.12%

$252.83M

Market Cap

-11.12

P/E

4.33

Forward P/E

66

Score

Price History